Dry Mouth Relief Market: How Are Pilocarpine and Cevimeline Serving Sjögren's Patients?
Prescription pharmacological dry mouth treatment — pilocarpine and cevimeline as muscarinic receptor agonists stimulating residual salivary gland secretion in Sjögren's syndrome and radiation-induced xerostomia — represents the pharmaceutical dry mouth market serving patients with more severe salivary hypofunction, with the Dry Mouth Relief Market reflecting prescription...
0 Comentários 0 Compartilhamentos 29 Visualizações 0 Anterior